CR9954A - Derivados de pirazina - Google Patents

Derivados de pirazina

Info

Publication number
CR9954A
CR9954A CR9954A CR9954A CR9954A CR 9954 A CR9954 A CR 9954A CR 9954 A CR9954 A CR 9954A CR 9954 A CR9954 A CR 9954A CR 9954 A CR9954 A CR 9954A
Authority
CR
Costa Rica
Prior art keywords
compounds
pirazine
derivatives
preparation
pirazine derivatives
Prior art date
Application number
CR9954A
Other languages
English (en)
Inventor
Richard Gibson Kart
Poinsard Cedric
Susanne Glossop Melanie
Martin Denton Stephen
Ian Kemp Mark
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of CR9954A publication Critical patent/CR9954A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invencion se refiere a compuestos de formula y a sales y solvatos farmaceuticamente aceptables de los mismos, a procedimientos para su preparacion, a intermedios utiles en su preparacion y a composiciones que contienen dichos compuestos, y a los usos de dichos compuestos para el tratamiento de dolor.
CR9954A 2005-11-04 2008-05-07 Derivados de pirazina CR9954A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73366205P 2005-11-04 2005-11-04

Publications (1)

Publication Number Publication Date
CR9954A true CR9954A (es) 2008-05-28

Family

ID=37890558

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9954A CR9954A (es) 2005-11-04 2008-05-07 Derivados de pirazina

Country Status (27)

Country Link
US (1) US7572797B2 (es)
EP (1) EP1945630B1 (es)
JP (1) JP2009514937A (es)
KR (1) KR20080066073A (es)
CN (1) CN101356169A (es)
AP (1) AP2008004468A0 (es)
AR (1) AR057855A1 (es)
AT (1) ATE525372T1 (es)
AU (1) AU2006310215A1 (es)
BR (1) BRPI0618129A2 (es)
CA (1) CA2624621C (es)
CR (1) CR9954A (es)
DO (1) DOP2006000243A (es)
EA (1) EA200801011A1 (es)
EC (1) ECSP088412A (es)
ES (1) ES2371932T3 (es)
GT (1) GT200600475A (es)
IL (1) IL191059A0 (es)
MA (1) MA29926B1 (es)
NL (1) NL2000284C2 (es)
NO (1) NO20082496L (es)
PE (1) PE20070715A1 (es)
TN (1) TNSN08196A1 (es)
TW (1) TW200804353A (es)
UY (1) UY29893A1 (es)
WO (1) WO2007052123A2 (es)
ZA (1) ZA200803671B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
EP1741708A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
JP2010526051A (ja) * 2007-05-03 2010-07-29 ファイザー・リミテッド 疼痛を治療するためのｎａｖ１．８チャネルモジュレーターとしてのｎ−［６−アミノ−５−（フェニル）ピラジン−２−イル］−イソオキサゾール−４−カルボキサミド誘導体および関連化合物
WO2008135826A2 (en) 2007-05-03 2008-11-13 Pfizer Limited 2 -pyridine carboxamide derivatives as sodium channel modulators
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
EP2231280B1 (en) 2007-12-10 2016-08-10 Novartis AG Amiloride-like Pyrazine-carboxamides as ENaC blockers
KR20100124262A (ko) 2008-02-13 2010-11-26 에자이 알앤드디 매니지먼트 가부시키가이샤 비시클로아민 유도체
BRPI0912267A2 (pt) 2008-05-23 2015-10-13 Amira Pharmaceuticals Inc sal farmaceuticamente aceitável, composição farmacêutica, artigo de fabricação, métodos para tratar asma, rinite alérgica, doença, lesões gástricas e dor, métodos para prevenir broncoconstrição e rinite alérgica, uso de um sal farmaceuticamente aceitável, e, processo para a preparação de um sal farmaceuticamente aceitável.
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) * 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013161312A1 (en) * 2012-04-25 2013-10-31 Raqualia Pharma Inc. Pyrrolopyridinone derivatives as ttx-s blockers
TWI644899B (zh) * 2013-02-04 2018-12-21 健生藥品公司 Ｆｌａｐ調節劑
US9079866B2 (en) 2013-02-04 2015-07-14 Janssen Pharmaceutica Nv Flap modulators
CA2960274A1 (en) * 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamide compounds
AR103807A1 (es) 2015-02-27 2017-06-07 Calcimedica Inc Tratamiento de la pancreatitis
JP6738575B2 (ja) * 2015-08-07 2020-08-12 カルシメディカ，インク． 脳卒中および外傷性脳損傷の処置のためのｃｒａｃチャネル阻害剤の使用
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds
EP4121089A4 (en) 2020-03-20 2024-04-10 Calcimedica, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACUTE LUNG LESION AND ACUTE RESPIRATORY DISTRESS SYNDROME
US12522589B2 (en) 2020-11-13 2026-01-13 Calcimedica, Inc. Synthesis of CRAC channel inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
AU2002343557A1 (en) * 2001-11-21 2003-06-10 Pharmacia And Upjohn Company Substituted aryl 1,4-pyrazine derivatives
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1678160A1 (en) * 2003-10-27 2006-07-12 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
DE602005015742D1 (de) * 2004-10-22 2009-09-10 Janssen Pharmaceutica Nv Aromatische amide als hemmer der c-fms-kinase

Also Published As

Publication number Publication date
EA200801011A1 (ru) 2009-02-27
EP1945630A2 (en) 2008-07-23
ECSP088412A (es) 2008-05-30
NL2000284C2 (nl) 2007-09-28
DOP2006000243A (es) 2007-05-31
US20070105872A1 (en) 2007-05-10
NL2000284A1 (nl) 2007-05-07
TNSN08196A1 (fr) 2009-10-30
AR057855A1 (es) 2007-12-19
AU2006310215A1 (en) 2007-05-10
ZA200803671B (en) 2009-03-25
CN101356169A (zh) 2009-01-28
ES2371932T3 (es) 2012-01-11
CA2624621C (en) 2010-11-30
US7572797B2 (en) 2009-08-11
CA2624621A1 (en) 2007-05-10
GT200600475A (es) 2007-07-06
AP2008004468A0 (en) 2008-06-30
MA29926B1 (fr) 2008-11-03
JP2009514937A (ja) 2009-04-09
NO20082496L (no) 2008-07-24
ATE525372T1 (de) 2011-10-15
EP1945630B1 (en) 2011-09-21
WO2007052123A3 (en) 2007-07-12
KR20080066073A (ko) 2008-07-15
PE20070715A1 (es) 2007-08-11
IL191059A0 (en) 2008-12-29
BRPI0618129A2 (pt) 2011-08-16
WO2007052123A2 (en) 2007-05-10
UY29893A1 (es) 2007-06-29
TW200804353A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
CR9954A (es) Derivados de pirazina
CR8859A (es) Derivados de piridina
DOP2009000254A (es) Derivados de piridina
CU20110145A7 (es) Derivados de sulfonamida
AR055076A1 (es) Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica.
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
UY31471A1 (es) Derivados bis-(sulfonilamino) en terapia 066
CR11106A (es) Inhibidores de cinasa p710 s6
UY31046A1 (es) Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
UY30460A1 (es) Compuestos terapéuticos
UY28671A1 (es) Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
HN2008001666A (es) Derivados acidos de cicloalquilamino
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
CR10376A (es) Derivados de terfenil para el tratamiento de la enfermedad de alzheimer
HN2003000379A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
PA8589801A1 (es) Aminoalcoxiindoles
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
GT200400143A (es) Compuestos
PA8653801A1 (es) Derivados de octahidropirrolo [3,4-c] pirrol
UY29817A1 (es) Nuevos compuestos de azetidina, composiciones farmacéuticas que los contienen, procesos de preparación y uso terapéutico de los mismos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)